AG NPP709 is at the moment available on the market; having said that, no study has investigated the effect of AG NPP709 in individuals with COPD. As a result, the goal of this research was to evaluate the efficacy of AG NPP709 in individuals with Continual bronchitis sort COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and